Joey Grochmal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joey Grochmal has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Rajiv Midha
3 shared publicationsAdam J. Reid
2 shared publicationsArthur W. English
2 shared publicationsChristine Radtke
2 shared publicationsDai Matsuse
2 shared publicationsGautam Rangavajla
2 shared publications
Latest Publications
- Open Access
- 30 June 2022
- Published by The Korean Spinal Neurosurgery Society in Neurospine
- Vol. 19 (2) , 283-296
Established and Emerging Therapies in Acute Spinal Cord Injury
Acute spinal cord injury (SCI) is devastating for patients and their caretakers and has an annual incidence of 20–50 per million people. Following initial assessment with appropriate physical examination and imaging, patients who are deemed surgical candidates should undergo decompression with stabilization. Earlier intervention can improve neurological recovery in the post-operative period while allowing earlier mobilization. Optimized medical management is paramount to improve outcomes. Emerging strategies for managing SCI in the acute period stem from an evolving understanding of the pathophysiology of the injury. General areas of focus include ischemia prevention, reduction of secondary injury due to inflammation, modulation of the cytotoxic and immune response, and promotion of cellular regeneration. In this article, we review established, emerging, and novel experimental therapies. Continued translational research on these methods will improve the feasibility of bench-to-bedside innovations in treating patients with acute SCI.
- 30 June 2022
- Published by The Korean Spinal Neurosurgery Society in Neurospine
- Vol. 19 (2) , 283-296
Open AccessEstablished and Emerging Therapies in Acute Spinal Cord Injury
Acute spinal cord injury (SCI) is devastating for patients and their caretakers and has an annual incidence of 20–50 per million people. Following initial assessment with appropriate physical examination and imaging, patients who are deemed surgical candidates should undergo decompression with stabilization. Earlier intervention can improve neurological recovery in the post-operative period while allowing earlier mobilization. Optimized medical management is paramount to improve outcomes. Emerging strategies for managing SCI in the acute period stem from an evolving understanding of the pathophysiology of the injury. General areas of focus include ischemia prevention, reduction of secondary injury due to inflammation, modulation of the cytotoxic and immune response, and promotion of cellular regeneration. In this article, we review established, emerging, and novel experimental therapies. Continued translational research on these methods will improve the feasibility of bench-to-bedside innovations in treating patients with acute SCI.
- 16 April 2015
- Published by S. Karger AG in Cells Tissues Organs
- Vol. 200 (1) , 1-4
Title Page / Table of Contents
- 16 April 2015
- Published by S. Karger AG in Cells Tissues Organs
- Vol. 200 (1) , 1-4
Title Page / Table of Contents
- 16 April 2015
- Published by S. Karger AG in Cells Tissues Organs
- Vol. 200 (1) , 92
Author and Subject Index Vol. 200, No. 1, 2014
- 16 April 2015
- Published by S. Karger AG in Cells Tissues Organs
- Vol. 200 (1) , 92
Author and Subject Index Vol. 200, No. 1, 2014
- 1 January 2014
- Published by S. Karger AG in Cells Tissues Organs
- Vol. 200 (1) , 13-22
Recent Advances in Stem Cell-Mediated Peripheral Nerve Repair
A major advance in the field of peripheral nerve repair has been the advent of stem and progenitor cell use to supplement the regenerative environment in animal models of nerve injury. As Schwann cell replacements, stem cells may be even better suited to promoting regeneration in these scenarios. We review the recent literature detailing the search for the definitive Schwann cell replacement cell, including a look at genetic modification of transplanted cells for nerve injury repair.
- 1 January 2014
- Published by S. Karger AG in Cells Tissues Organs
- Vol. 200 (1) , 13-22
Recent Advances in Stem Cell-Mediated Peripheral Nerve Repair
A major advance in the field of peripheral nerve repair has been the advent of stem and progenitor cell use to supplement the regenerative environment in animal models of nerve injury. As Schwann cell replacements, stem cells may be even better suited to promoting regeneration in these scenarios. We review the recent literature detailing the search for the definitive Schwann cell replacement cell, including a look at genetic modification of transplanted cells for nerve injury repair.